Late toxicities after intensity-modulated radiotherapy for nasopharyngeal carcinoma: patient and treatment-related risk factors

[1] Butler EB(1999)Smart (simultaneous modulated accelerated radiation therapy) boost: a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy Int J Radiat Oncol Biol Phys 45 21-32

[2] Teh BS(2001)A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results Int J Radiat Oncol Biol Phys 49 907-916

[3] Grant WH(2001)Three-dimensional dosimetric evaluation of a conventional radiotherapy technique for treatment of nasopharyngeal carcinoma Radiother Oncol 58 143-153

[4] Uhl BM(2006)Experience in fractionated stereotactic body radiation therapy boost for newly diagnosed nasopharyngeal carcinoma Int J Radiat Oncol Biol Phys 66 1408-1414

[5] Kuppersmith RB(2009)Effect of cisplatin on parotid gland function in concomitant radiochemotherapy Int J Radiat Oncol Biol Phys 75 1475-1480

[6] Chiu JK(2010)Radiation dose-volume effects in the brain Int J Radiat Oncol Biol Phys 76 S20-S27

[7] Donovan DT(2009)Major late toxicities after conformal radiotherapy for nasopharyngeal carcinoma: patient and treatment-related risk factors Int J Radiat Oncol Biol Phys 73 1121-1128

[8] Woo SY(2005)Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience Int J Radiat Oncol Biol Phys 61 1107-1116

[9] Chao KS(2002)Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience Int J Radiat Oncol Biol Phys 53 12-22

[10] Jo Deasy(2009)Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225 J Clin Oncol 27 3684-3690

[1] Butler EB(1999)Smart (simultaneous modulated accelerated radiation therapy) boost: a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy Int J Radiat Oncol Biol Phys 45 21-32

[2] Teh BS(2001)A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results Int J Radiat Oncol Biol Phys 49 907-916

[3] Grant WH(2001)Three-dimensional dosimetric evaluation of a conventional radiotherapy technique for treatment of nasopharyngeal carcinoma Radiother Oncol 58 143-153

[4] Uhl BM(2006)Experience in fractionated stereotactic body radiation therapy boost for newly diagnosed nasopharyngeal carcinoma Int J Radiat Oncol Biol Phys 66 1408-1414

[5] Kuppersmith RB(2009)Effect of cisplatin on parotid gland function in concomitant radiochemotherapy Int J Radiat Oncol Biol Phys 75 1475-1480

[6] Chiu JK(2010)Radiation dose-volume effects in the brain Int J Radiat Oncol Biol Phys 76 S20-S27

[7] Donovan DT(2009)Major late toxicities after conformal radiotherapy for nasopharyngeal carcinoma: patient and treatment-related risk factors Int J Radiat Oncol Biol Phys 73 1121-1128

[8] Woo SY(2005)Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience Int J Radiat Oncol Biol Phys 61 1107-1116

[9] Chao KS(2002)Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience Int J Radiat Oncol Biol Phys 53 12-22

[10] Jo Deasy(2009)Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225 J Clin Oncol 27 3684-3690